163 related articles for article (PubMed ID: 31616903)
1. Use of hormones in doping and cancer risk.
De Santi M; Baldelli G; Brandi G; ;
Ann Ig; 2019; 31(6):590-594. PubMed ID: 31616903
[TBL] [Abstract][Full Text] [Related]
2. Doping with growth hormone/IGF-1, anabolic steroids or erythropoietin: is there a cancer risk?
Tentori L; Graziani G
Pharmacol Res; 2007 May; 55(5):359-69. PubMed ID: 17349798
[TBL] [Abstract][Full Text] [Related]
3. [Doping and urologic tumors].
Pinto F; Sacco E; Volpe A; Gardi M; Totaro A; Calarco A; Racioppi M; Gulino G; D'Addessi A; Bassi PF
Urologia; 2010; 77(2):92-9. PubMed ID: 20890867
[TBL] [Abstract][Full Text] [Related]
4. [Growth hormone and IGF-1 as doping agents in competitive sport].
Jóźków P; Medraś M
Endokrynol Pol; 2009; 60(5):389-94. PubMed ID: 19885810
[TBL] [Abstract][Full Text] [Related]
5. IGF-I abuse in sport.
Guha N; Dashwood A; Thomas NJ; Skingle AJ; Sönksen PH; Holt RI
Curr Drug Abuse Rev; 2009 Sep; 2(3):263-72. PubMed ID: 20443773
[TBL] [Abstract][Full Text] [Related]
6. Growth hormone, IGF-I and insulin and their abuse in sport.
Holt RI; Sönksen PH
Br J Pharmacol; 2008 Jun; 154(3):542-56. PubMed ID: 18376417
[TBL] [Abstract][Full Text] [Related]
7. Human growth hormone abuse in male weightlifters.
Brennan BP; Kanayama G; Hudson JI; Pope HG
Am J Addict; 2011; 20(1):9-13. PubMed ID: 21175915
[TBL] [Abstract][Full Text] [Related]
8. Insulin-like growth factor-I (IGF-I) misuse in athletes and potential methods for detection.
Guha N; Cowan DA; Sönksen PH; Holt RI
Anal Bioanal Chem; 2013 Dec; 405(30):9669-83. PubMed ID: 23934394
[TBL] [Abstract][Full Text] [Related]
9. Use of growth hormone, IGF-I, and insulin for anabolic purpose: Pharmacological basis, methods of detection, and adverse effects.
Anderson LJ; Tamayose JM; Garcia JM
Mol Cell Endocrinol; 2018 Mar; 464():65-74. PubMed ID: 28606865
[TBL] [Abstract][Full Text] [Related]
10. Insulin-like growth factor I and insulin and their abuse in sport.
Erotokritou-Mulligan I; Holt RI
Endocrinol Metab Clin North Am; 2010 Mar; 39(1):33-43, viii. PubMed ID: 20122448
[TBL] [Abstract][Full Text] [Related]
11. Correlations of growth hormone (GH) and insulin-like growth factor I (IGF-I): effects of exercise and abuse by athletes.
De Palo EF; Gatti R; Lancerin F; Cappellin E; Spinella P
Clin Chim Acta; 2001 Mar; 305(1-2):1-17. PubMed ID: 11249917
[TBL] [Abstract][Full Text] [Related]
12. Growth hormone and physical performance.
Birzniece V; Nelson AE; Ho KK
Trends Endocrinol Metab; 2011 May; 22(5):171-8. PubMed ID: 21420315
[TBL] [Abstract][Full Text] [Related]
13. Does the GH-IGF axis play a role in cancer pathogenesis?
Cohen P; Clemmons DR; Rosenfeld RG
Growth Horm IGF Res; 2000 Dec; 10(6):297-305. PubMed ID: 11161960
[TBL] [Abstract][Full Text] [Related]
14. IGF-I abuse in sport: current knowledge and future prospects for detection.
Guha N; Sönksen PH; Holt RI
Growth Horm IGF Res; 2009 Aug; 19(4):408-11. PubMed ID: 19467615
[TBL] [Abstract][Full Text] [Related]
15. Doping and sports endocrinology: growth hormone, IGF-1, insulin, and erythropoietin.
García-Arnés JA; García-Casares N
Rev Clin Esp (Barc); 2023 Mar; 223(3):181-187. PubMed ID: 36736729
[TBL] [Abstract][Full Text] [Related]
16. The effect of sports injury on insulin-like growth factor-I and type 3 procollagen: implications for detection of growth hormone abuse in athletes.
Erotokritou-Mulligan I; Bassett EE; Bartlett C; Cowan D; McHugh C; Seah R; Curtis B; Wells V; Harrison K; Sönksen PH; Holt RI;
J Clin Endocrinol Metab; 2008 Jul; 93(7):2760-3. PubMed ID: 18413420
[TBL] [Abstract][Full Text] [Related]
17. The growth hormone/insulin-like growth factor-I axis hormones and bone markers in elite athletes in response to a maximum exercise test.
Ehrnborg C; Lange KH; Dall R; Christiansen JS; Lundberg PA; Baxter RC; Boroujerdi MA; Bengtsson BA; Healey ML; Pentecost C; Longobardi S; Napoli R; Rosén T;
J Clin Endocrinol Metab; 2003 Jan; 88(1):394-401. PubMed ID: 12519882
[TBL] [Abstract][Full Text] [Related]
18. Demographic factors influencing the GH system: Implications for the detection of GH doping in sport.
Nelson AE; Ho KK
Growth Horm IGF Res; 2009 Aug; 19(4):327-32. PubMed ID: 19481485
[TBL] [Abstract][Full Text] [Related]
19. Biochemical markers of insulin-like growth factor-I misuse in athletes: the response of serum IGF-I, procollagen type III amino-terminal propeptide, and the GH-2000 score to the administration of rhIGF-I/rhIGF binding protein-3 complex.
Guha N; Erotokritou-Mulligan I; Bartlett C; Nevitt SP; Francis M; Bassett EE; Cowan DA; Sönksen PH; Holt RI
J Clin Endocrinol Metab; 2014 Jun; 99(6):2259-68. PubMed ID: 24606087
[TBL] [Abstract][Full Text] [Related]
20. High dose growth hormone exerts an anabolic effect at rest and during exercise in endurance-trained athletes.
Healy ML; Gibney J; Russell-Jones DL; Pentecost C; Croos P; Sönksen PH; Umpleby AM
J Clin Endocrinol Metab; 2003 Nov; 88(11):5221-6. PubMed ID: 14602753
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
